复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02196 复星医药

未开盘 11-22 16:08:13

14.000

-0.540

-3.71%

最高14.600	最低13.880	成交量417.02万
今开14.500	昨收14.540	日振幅4.95%
总市值373.54亿	流通市值76.72亿	总股本26.68亿
成交额5,908万	换手率0.76%	流通股本5.48亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02196","market":"HK","secType":"STK","nameCN":"复星医药","latestPrice":14,"timestamp":1732262893030,"preClose":14.54,"halted":0,"volume":4170242,"delay":0,"floatShares":548000000,"shares":2668120211,"eps":0.96051246,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.54,"latestTime":"11-22 16:08:13","open":14.5,"high":14.6,"low":13.88,"amount":59083289,"amplitude":0.049519,"askPrice":14.02,"askSize":8000,"bidPrice":14,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.8406427470636312,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"listingDate":1351526400000,"adjPreClose":14.54,"dividendRate":0.02072,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":1.5522657371506137,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600196","market":"SH","secType":"STK","nameCN":"复星医药","latestPrice":26.24,"timestamp":1732258800000,"preClose":27.29,"halted":0,"volume":19745900,"delay":0,"premium":"-50.35"}},"requestUrl":"/m/hq/s/02196/tweets","defaultTab":"tweets","newsList":[{"id":"2485306798","title":"打造本土创新药械“链主” 这家头部药企在探索","url":"https://stock-news.laohu8.com/highlight/detail?id=2485306798","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485306798?lang=zh_cn&edition=full","pubTime":"2024-11-24 19:28","pubTimestamp":1732447701,"startTime":"0","endTime":"0","summary":"新华财经上海11月24日电（记者杜康）作为全国生物医药领域最早在A股上市的民营企业之一，总部位于上海的复星医药今年迎来了成立30周年。回顾三十年，中国生物医药产业从发芽、生长、开花到结果，形成了今天创新药械竞相涌现的热潮。身处这股大潮的复星医药，是中国生物医药产业三十年发展的亲历者、见证者和受益者。“三十年来，我们完整地经历了全国制药行业从仿制为主到创新驱动的进阶过程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411243248887131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1515","BK1161","02196","BK1191","BK1593","06978"],"gpt_icon":0},{"id":"2485695253","title":"标普最新评级报告：复星美元债成功发行提升信用指标，流动性安全垫充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2485695253","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485695253?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:59","pubTimestamp":1732273142,"startTime":"0","endTime":"0","summary":"11月21日，标普全球评级发表更新报告，对复星国际近期美元债券的成功发行表达了高度的认可。标普认为复星本次美元债的成功发行对集团融资渠道的拓宽起到积极作用，维持复星国际“稳定”展望评级不变。本次新债发行的同时，复星宣布要约等额的2025年到期的美元债，以确保有息债务总额不因新债发行而上升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122190052a24dbdd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122190052a24dbdd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","600196"],"gpt_icon":0},{"id":"2485533132","title":"复星医药推进复宏汉霖私有化 交易审批存不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2485533132","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485533132?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:45","pubTimestamp":1732272342,"startTime":"0","endTime":"0","summary":"财中社11月22日电复星医药（600196/02196）发布关于对控股子公司复宏汉霖生物技术股份有限公司实施吸收合并及私有化的进展公告。根据公告，公司董事会于2024年6月24日及8月23日批准了对复宏汉霖的私有化方案，控股子公司复星新药将以现金及/或换股方式收购并注销复宏汉霖的全部股份，完成后复宏汉霖的法人主体将予以注销，所有资产、负债及权益将由复星新药承继。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411223248380674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02696","BK1593","BK1161","BK1515","02196","BK1191"],"gpt_icon":0},{"id":"2485302142","title":"复星医药子公司健嘉康复股权激励计划进展显著，关联交易引关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2485302142","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485302142?lang=zh_cn&edition=full","pubTime":"2024-11-22 18:05","pubTimestamp":1732269924,"startTime":"0","endTime":"0","summary":"财中社11月22日电复星医药（600196/02196）发布关于控股子公司健嘉康复股权激励计划实施进展暨关联交易的公告。公告指出，健嘉康复于2023年9月14日批准的股权激励计划中，新增发行注册资本共计7500万元，约占增发后注册资本总额的20%。截至本公告日，计划已完成两次跟投授予和两次期权授予，涉及金额分别为3500万元和2067万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411223248357297.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","02196","BK1191","BK1593"],"gpt_icon":0},{"id":"2484457189","title":"【新股IPO】九源基因(02566)今日起招股 入场费2,537.33港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484457189","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484457189?lang=zh_cn&edition=full","pubTime":"2024-11-20 08:39","pubTimestamp":1732063175,"startTime":"0","endTime":"0","summary":"金吾财讯 | 九源基因 今日起招股，拟发行4539.88万股H股，其中10%为香港公开发售，90%为国际配售。每股招股价介于11.48港元-12.56港元，每手200股，入场费2,537.33港元。股份预期将于11月28日挂牌上市。基石投资者包括和达金源(香港)、复星医药全资附属复星实业（香港）、健友股份全资持有的香港健友实业、阿里健康间接全资拥有的阿里健康香港、九州通全资附属Jointown International、君亭酒店创办人吴启元、以及Delta Capital HK。","market":"nz","thumbnail":"https://static.szfiu.com/news/20220324/ZDg5MGY3YjA4MWNiNDkyZjgyMTczYjhiYWU0ZDI5OWEyNTc1MTQyMDQxMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/ZDg5MGY3YjA4MWNiNDkyZjgyMTczYjhiYWU0ZDI5OWEyNTc1MTQyMDQxMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1948029","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","BK1142","BK1591","BK1584","02196","BK1247","BK1189","BK1589","BK1515","BK1593","BK1610","BK1502","BK1501","BK1191","00241"],"gpt_icon":0},{"id":"2484008839","title":"九源基因(02566.HK)预计11月28日上市 引入复星医药等多家基石","url":"https://stock-news.laohu8.com/highlight/detail?id=2484008839","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484008839?lang=zh_cn&edition=full","pubTime":"2024-11-20 07:03","pubTimestamp":1732057406,"startTime":"0","endTime":"0","summary":"格隆汇11月20日丨九源基因发布公告，公司拟全球发售4539.88万股H股，中国香港发售股份454万股，国际发售股份4085.88万股；2024年11月20日至11月25日招股，预期定价日为11月26日；发售价将为每股发售股份11.48-12.56港元，每手买卖单位为200股；华泰国际为独家保荐人；预期股份将于2024年11月28日开始在联交所买卖。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120070335abd044b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120070335abd044b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK0096","BK0183","BK0196","BK0188","BK0028","BK0175","600196","BK0239","BK0187","BK0060","BK0012"],"gpt_icon":0},{"id":"2484998217","title":"券商看好复星国际战略聚焦、多元业务稳健，给予“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2484998217","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484998217?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:10","pubTimestamp":1732000208,"startTime":"0","endTime":"0","summary":"近日，东北证券发表研究报告，认为复星国际在“科创+全球化布局”双轮驱动下，战略定位清晰、四大板块业务稳健，此外还通过优化资产配置，现金流稳步改善。东北证券对复星的未来发展前景持乐观态度，并给予“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119152331a24502da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119152331a24502da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00656","02196","600196"],"gpt_icon":0},{"id":"2483988827","title":"帕金森药物上新，由复星医药引入","url":"https://stock-news.laohu8.com/highlight/detail?id=2483988827","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483988827?lang=zh_cn&edition=full","pubTime":"2024-11-14 17:53","pubTimestamp":1731578026,"startTime":"0","endTime":"0","summary":"帕金森用药上新据头豹研究院，按药物作用机制划分，帕金森病药物主要有6大类，具体包括抗胆碱能药物、促多巴胺释放药物、多巴胺替代药物、多巴胺受体激动剂、B型单胺氧化酶抑制剂、COMT抑制剂。2018年，复星医药与葡萄牙BIAL公司达成协议，引进该创新药。抗帕金森病药物指用于治疗帕金森病引起的静止震颤、肌肉强直、运动迟缓和共济失调等症状的一类药物。这是全球首个治疗帕金森病的长效缓释微球制剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114184233abc0d139&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114184233abc0d139&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0183","BK0196","BK0012","600196","BK0096","BK0175","BK0060","BK0188","BK0028","BK0187","02196","BK0239"],"gpt_icon":0},{"id":"2483022389","title":"复星医药11月13日遭主力抛售590万元 环比增加472.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483022389","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483022389?lang=zh_cn&edition=full","pubTime":"2024-11-13 16:15","pubTimestamp":1731485755,"startTime":"0","endTime":"0","summary":"11月13日, 复星医药股价跌0.92%，报收15.08元，成交金额4961万元，换手率0.61%，振幅2.37%，量比0.64。复星医药今日主力资金净流出590万元，连续3日净流出，上一交易日主力净流出103万元，今日环比增加472.82%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为46.15%，平均跌幅为1.85%。该股近5个交易日下跌1.05%，主力资金累计净流出320万元；近20日主力资金累计净流入10万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161619abbcb0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161619abbcb0a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","02196","BK1191","BK1515"],"gpt_icon":0},{"id":"2482740457","title":"股价大涨后，复星“背书”的金徽酒第四大股东再次减持能否成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2482740457","media":"深圳商报","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482740457?lang=zh_cn&edition=full","pubTime":"2024-11-12 14:44","pubTimestamp":1731393875,"startTime":"0","endTime":"0","summary":"在上一次减持没有完成后不到三个月，金徽酒第四大股东再度宣布减持。但三个月后的8月底，金徽酒发布公告，铁晟叁号转让数量为0，这就是说，公司一股都没有转让成功。铁晟叁号首次减持之所以没有成行，或许是因为金徽酒股价走低造成的。转让总价款5.99亿元，转让完成后，豫园股份仍持有金徽酒20%的股份。2023年9月1日，豫园股份减持部分完成过户，铁晟叁号正式成为金徽酒的股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112145608a22f50d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112145608a22f50d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","02196","BK1191"],"gpt_icon":0},{"id":"2482724841","title":"复星医药刘毅：我们是进博会参与者和受益者","url":"https://stock-news.laohu8.com/highlight/detail?id=2482724841","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482724841?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:42","pubTimestamp":1731289347,"startTime":"0","endTime":"0","summary":"11月5日至10日，第七届中国国际进口博览会在上海举办，152个国家、地区和国际组织参加国家展和企业展，整体展览展示面积超42万平方米。复星医药在七年进博之旅中，“展品变商品”“展商变投资商”的生动“进博故事”不断涌现，充分印证了进博会“溢出效应”所带来的产业动能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411113235265654.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411113235265654.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02196","BK1191","BK1515","BK1593"],"gpt_icon":0},{"id":"2481017017","title":"复星医药（600196）股东上海复星高科技(集团)有限公司质押740万股，占总股本0.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481017017","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481017017?lang=zh_cn&edition=full","pubTime":"2024-11-08 21:19","pubTimestamp":1731071996,"startTime":"0","endTime":"0","summary":"证券之星消息，复星医药11月8日公开信息显示，股东上海复星高科技(集团)有限公司向中国工商银行股份有限公司上海市长宁支行合计质押740.0万股，占总股本0.28%。质押详情见下表：截止本公告日，股东上海复星高科技(集团)有限公司已累计质押股份6.54亿股，占其持股总数的73.47%。复星医药主营业务：制药、医疗器械与医学诊断、医疗健康服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800041279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK1515","BK0028","BK0060","BK0175","BK0183","BK0239","BK0012","BK1593","BK0188","BK0196","02196","BK1191","600196","BK0187"],"gpt_icon":0},{"id":"2481126864","title":"复星医药(02196)控股股东复星高科技质押740万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2481126864","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481126864?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:53","pubTimestamp":1731059607,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)公布，公司于 2024 年 11 月 8 日接到控股股东上海复星高科技(集团)有限公司(以下简称“复星高科技”)的通知，其已将所持有公司的部分 A 股股份办理质押手续。2024 年 11 月 7 日，复星高科技质押740万股股份予中国工商银行股份有限公司上海市长宁支行。本次办理股份质押后，复星高科技累计质押本公司股份(均为 A 股)数量为6.538亿股，约占截至 2024 年 11 月 7 日公司股份总数的 24.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK1515","BK0028","BK0060","BK0175","BK0183","BK0239","BK0012","BK1593","BK0188","BK0196","02196","BK1191","600196","BK0187"],"gpt_icon":0},{"id":"2481126154","title":"复星医药控股股东所持68%股份已质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2481126154","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481126154?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:39","pubTimestamp":1731058787,"startTime":"0","endTime":"0","summary":"财中社11月8日电复星医药 发布关于股东部分股份质押的公告。本次质押后，复星高科技累计质押股份数量为6.54亿股，约占其所持股份的68.00%，占本公司股份总数的24.47%。同时，复星高科技及其一致行动人合计持有本公司9.68亿股股份，质押后累计质押数量同样为6.54亿股，占其所持股份的67.55%。2024年前三季度，复星医药实现收入309.12亿元，归母净利润20.11亿元。文章来源：财中社复星医药控股股东所持68%股份已质押","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108175004abad6126&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108175004abad6126&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","02196","BK1191"],"gpt_icon":0},{"id":"2481911901","title":"港股概念追踪|北京扩大造血干细胞移植医保报销范围   干细胞相关医药企业受益（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2481911901","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481911901?lang=zh_cn&edition=full","pubTime":"2024-11-08 14:07","pubTimestamp":1731046070,"startTime":"0","endTime":"0","summary":"北京市医保局近日发布通知，扩大造血干细胞移植医保报销范围。本市医保参保人如果符合12类适应证，进行造血干细胞移植的费用纳入医保报销。从北京市药品监督管理局网站搜索发现，获得全国第一张干细胞药品生产许可证的干细胞公司是铂生卓越生物科技有限公司，发证日期为2024年5月30日，有效期至2029年5月29日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1197","HSTECH","YANG","BK1515","02196","BK1593","02607","BK1191","HSCEI"],"gpt_icon":1},{"id":"2481167598","title":"南向资金11月7日净买入复星医药28.55万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2481167598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481167598?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:30","pubTimestamp":1731029416,"startTime":"0","endTime":"0","summary":"11月7日, 南向资金增持复星医药28.55万股，连续7日增持。截止当日收盘，港股通共持有复星医药30350.41万股，占流通股54.98%。复星医药近5个交易日上涨5.14%，港股通累计增持284.60万股；近20个交易日上涨1.43%，港股通累计增持1159.80万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093157ababa39c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108093157ababa39c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0183","BK0187","BK0188","600196","BK0175","BK0096","BK0060","BK0028","BK0196","02196","BK0239"],"gpt_icon":0},{"id":"2481695604","title":"南向资金11月5日净买入复星医药13.55万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2481695604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481695604?lang=zh_cn&edition=full","pubTime":"2024-11-06 09:30","pubTimestamp":1730856615,"startTime":"0","endTime":"0","summary":"11月5日, 南向资金增持复星医药13.55万股，连续5日增持。截止当日收盘，港股通共持有复星医药30280.46万股，占流通股54.85%。复星医药近5个交易日上涨5.35%，港股通累计增持360.65万股；近20个交易日下跌20.99%，港股通累计增持933.65万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106093154aba36c34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106093154aba36c34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600196","BK1515","BK1593","BK1191","02196"],"gpt_icon":0},{"id":"2481177574","title":"复星七赴进博 郭广昌：坚信中国高水平开放是时代机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2481177574","media":"凤凰网财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481177574?lang=zh_cn&edition=full","pubTime":"2024-11-05 19:23","pubTimestamp":1730805789,"startTime":"0","endTime":"0","summary":"11月5日，第七届中国国际进口博览会在国家会展中心（上海）开幕。2019年，Ion在进博会一经亮相就吸引了观众眼球。肺癌被称为癌症“头号杀手”，2022年中国新发肺癌高达106.06万例。肺癌患者5年生存率仅为19.7%，支气管镜检查是肺癌早期诊断的重要手段。截至今年第三季度，全球已安装了736套Ion，实施了超过15万例Ion手术。复星积极响应这一临床未满足的需求。今年，复星重点展示了奕凯达在淋巴瘤治疗领域“可及可愈”的最新进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105192130a21854a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105192130a21854a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1230","600196","00656","02196","BK1515","BK1593","BK1191"],"gpt_icon":0},{"id":"2481529450","title":"复星医药11月05日主力资金流入271万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481529450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481529450?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:15","pubTimestamp":1730794518,"startTime":"0","endTime":"0","summary":"11月05日, 复星医药股价涨1.99%，报收15.36元，成交金额7019万元，换手率0.84%，振幅2.52%，量比0.86。复星医药今日主力资金净流入271万元，连续3日净流入，上一交易日主力净流入358万元，今日环比减少24.30%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为60.00%，平均涨幅为1.57%。该股近5个交易日上涨5.49%，主力资金累计净流出38万元；近20日主力资金累计净流出2611万元，其中净流出天数为10日。该股主力净额占比0.03%，港股市场排名202/2644。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105161533aba13ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105161533aba13ef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1593","BK1515","02196"],"gpt_icon":0},{"id":"2480370825","title":"复星医药(02196.HK)两子公司药品注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2480370825","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480370825?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:58","pubTimestamp":1730714280,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布，旗下两家子公司分别各有一药物获得国家药品监督管理局受理其药品注册申请。两款药物都是集团自主研发的化学药品，一款用于治疗敏感细菌引起的炎症，另一款则用作治疗白血病。公司表示，截至9月针对两款新药物的累计研发投资分别为133万及257万元人民币。(vc/u)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-04 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220221174702240_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220221174702240_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1393971/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0183","BK0239","BK0060","600196","BK0028","BK0188","BK0012","BK0187","BK1593","BK0175","BK1191","BK0196","BK1515","BK0096","02196"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fosunpharma.com","stockEarnings":[{"period":"1week","weight":-0.0345},{"period":"1month","weight":-0.0371},{"period":"3month","weight":0.1419},{"period":"6month","weight":0.1264},{"period":"1year","weight":-0.2403},{"period":"ytd","weight":-0.1572}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复星医药（集团）股份有限公司是一家主要从事医药产品研发、制造与销售的中国公司。该公司经营五个分部。制药分部主要从事创新药、成熟医药产品制造和疫苗业务。医疗器械与医学诊断分部主要从事分子诊断、免疫诊断、微生物诊断等医疗美容器械的制造和销售。医疗健康服务分部主要从事线上线下一体化医疗服务平台的经营。医药分销和零售分部主要从事医药产品的批发零售。其他分部从事其他医药相关业务。该公司的产品主要用于肿瘤、免疫、中枢神经等治疗领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":-0.049472},{"month":2,"riseRate":0.75,"avgChangeRate":0.030189},{"month":3,"riseRate":0.666667,"avgChangeRate":0.053895},{"month":4,"riseRate":0.416667,"avgChangeRate":0.038772},{"month":5,"riseRate":0.416667,"avgChangeRate":0.023544},{"month":6,"riseRate":0.416667,"avgChangeRate":-0.030979},{"month":7,"riseRate":0.583333,"avgChangeRate":0.016786},{"month":8,"riseRate":0.25,"avgChangeRate":-0.056338},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.002922},{"month":10,"riseRate":0.5,"avgChangeRate":0.028405},{"month":11,"riseRate":0.461538,"avgChangeRate":0.044636},{"month":12,"riseRate":0.5,"avgChangeRate":0.024501}],"exchange":"SEHK","name":"复星医药","nameEN":"FOSUN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复星医药,02196,复星医药股票,复星医药股票老虎,复星医药股票老虎国际,复星医药行情,复星医药股票行情,复星医药股价,复星医药股市,复星医药股票价格,复星医药股票交易,复星医药股票购买,复星医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复星医药(02196)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复星医药(02196)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}